| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000234936.1 |
Ponatinib |
Brain lower grade glioma |
0.009830317 |
Resistant |
| ENSG00000234936.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.034756744 |
Sensitive |
| ENSG00000234936.1 |
Ponatinib |
Skin cutaneous melanoma |
0.014751951 |
Sensitive |
